Volume 70, Issue 9, Pages (November 2006)

Slides:

Advertisements

Similar presentations

A skeptical view of assisted home peritoneal dialysis

Advertisements

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.

Central venous catheter outcomes in nocturnal hemodialysis

F.H. Bender, J. Bernardini, B. Piraino Kidney International

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Beta blockers in the management of chronic kidney disease

Volume 70, Pages S138-S145 (November 2006)

Volume 70, Issue 8, Pages (October 2006)

Volume 70, Pages S38-S43 (November 2006)

Volume 59, Issue 5, Pages (May 2001)

Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.

Confounding: What it is and how to deal with it

Impact of new dialysis solutions on peritonitis rates

C-reactive protein and dialysis access

M. Kats, A.M. Hawxby, J. Barker, M. Allon Kidney International

Fibrin plug Kidney International Volume 78, Issue 9, (November 2010)

C-reactive protein and dialysis access

Volume 73, Pages S165-S172 (April 2008)

Volume 73, Issue 4, Pages (February 2008)

Volume 70, Pages S21-S25 (December 2006)

Volume 61, Issue 3, Pages (March 2002)

French peritoneal dialysis registry (RDPLF): Outline and main results

Anemia as a risk factor for chronic kidney disease

F.H. Bender, J. Bernardini, B. Piraino Kidney International

Volume 70, Issue 11, Pages (December 2006)

Volume 77, Issue 2, Pages (January 2010)

M. Kats, A.M. Hawxby, J. Barker, M. Allon Kidney International

Volume 73, Pages S5-S17 (April 2008)

Dedicated outpatient vascular access center decreases hospitalization and missed outpatient dialysis treatments R. Mishler, J.J. Sands, N.J. Ofsthun,

The analysis of survival data: the Kaplan–Meier method

Volume 70, Issue 12, Pages (December 2006)

Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory.

Blood pressure targets in hemodialysis patients

Locking of tunneled hemodialysis catheters with gentamicin and heparin

The third World Kidney Day: Looking back and thinking forward

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Microbiology and outcomes of peritonitis in North America

Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.

Volume 76, Issue 8, Pages (October 2009)

V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen

Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis N.-Y. Zalunardo, C.-L. Rose, I.W.Y.

Volume 71, Issue 12, Pages (June 2007)

Volume 69, Issue 1, Pages (January 2006)

Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients B. Bammens, P. Evenepoel, H. Keuleers,

American Journal of Kidney Diseases

Racial differences in survival of patients on dialysis

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Organ transplantation goes to the movies

Low triiodothyronine and survival in end-stage renal disease

Volume 70, Pages S84-S90 (November 2006)

Volume 70, Issue 8, Pages (October 2006)

Volume 72, Issue 2, Pages (July 2007)

Charles A. Herzog Kidney International

Volume 70, Issue 3, Pages (August 2006)

An unexpected finding during tunneled dialysis catheter exchange

Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate S. Aime, C. Canavese, P. Stratta Kidney International

Volume 70, Issue 5, Pages (September 2006)

Victoria R. Briggs, Badri M. Shrestha, Martin E. Wilkie

Volume 70, Issue 3, Pages (August 2006)

Volume 82, Issue 9, Pages (November 2012)

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

Ivan D. Maya, Michael Allon Kidney International

Survival of propensity matched incident peritoneal and hemodialysis patients in a United States health care system Victoria A. Kumar, Margo A. Sidell,

E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins

Volume 72, Issue 12, (December 2007)

Central venous catheter outcomes in nocturnal hemodialysis

Stephen Pastan, J. Michael Soucie, William M. McClellan

Volume 66, Issue 5, Pages (November 2004)

Presentation transcript:

Volume 70, Issue 9, Pages 1629-1635 (November 2006) Tunneled catheters' outcome optimization among diabetics on dialysis through antibiotic-lock placement A.K. Saxena, B.R. Panhotra, D.S. Sundaram, A. Al-Hafiz, M. Naguib, C.K. Venkateshappa, B.A. Abu-Oun, S.M.N. Hussain, A.M.A.-A. Al Ghamdi Kidney International Volume 70, Issue 9, Pages 1629-1635 (November 2006) DOI: 10.1038/sj.ki.5001776 Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 1 Kaplan–Meier cumulative survival curves demonstrating the probability of thrombosis-free survival of TCCs (IJC and SC) group I (diabetic ESRD patients with cefotaxime–heparin ‘lock’) and group II (with heparin alone) on long-term HD. Kidney International 2006 70, 1629-1635DOI: (10.1038/sj.ki.5001776) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 2 Kaplan–Meier cumulative survival curves demonstrating the probability of infection-free survival of TCCs (IJC and SC) group I (diabetic ESRD patients with cefotaxime–heparin ‘lock’) and group II (with heparin alone) on long-term HD. Kidney International 2006 70, 1629-1635DOI: (10.1038/sj.ki.5001776) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 3 Kaplan–Meier cumulative survival curves demonstrating the probability of thrombosis and infection-free survival of TCCs (IJC and SC) group I (diabetic ESRD patients with cefotaxime–heparin ‘lock’) and group II (with heparin-alone) on long-term HD. Kidney International 2006 70, 1629-1635DOI: (10.1038/sj.ki.5001776) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 4 Study design and plan of randomization. Kidney International 2006 70, 1629-1635DOI: (10.1038/sj.ki.5001776) Copyright © 2006 International Society of Nephrology Terms and Conditions